Try our Advanced Search for more refined results
Product Liability - September, 2006
20 articles
- Report: FDA Should Improve Defibrillator Communication
- Jury Deadlocks In Wyeth Hormone Replacement Trial
- Merck Scores Second Win In Vioxx Onslaught
- EU Regulator To Re-Examine Safety Of Common Drugs
- As Vioxx Deadline Looms, Merck Faces More Suits
- FDA Plans Studies Of On-The-Market Medications
- AMS Health Sciences Settles Ephedra Suit
- Four Mayer Brown Litigation Partners Head To MoFo
- Wyeth Wins First Hormone Replacement Therapy Case
- Clotting Data Prompts FDA To Promise Stent Review
- Guidant Buries One Hatchet In Defibrillator Fallout
- Execs Sentenced For Marketing Unapproved Devices
- Biopure Escapes Damages In SEC Suit, GC Doesn't
- FDA Whistleblower Blasts New Merck Painkiller
- Jury Mulls Evidence In Wyeth Premarin Trial
- FDA Advisors Question Mercury Fillings Report
- Bondholders Get Behind Congoleum Ch. 11 Plan
- Law Firm's Investigation Finds Merck Innocent
- Pfizer Faces New Personal-Injury Suits Over Lipitor
- ABB Resolves Lummus Asbestos Claims